Comparative Safety and Efficacy of Left Atrial Appendage Occlusion with the Watchman Device and Amplatzer Cardiac Plug: Results of the Russian National Registry
Table 1
Patients characteristics.
Total
WD
ACP
value
Age (years)
0.795
Female gender % ()
44.5 (89)
45.4 (49)
43.5 (40)
0.788
Permanent AF % ()
46.5 (93)
50 (54)
42.4 (39)
0.539
AH % ()
84.3 (166)
90.7 (98)
76.4 (68)
0.006
DM % ()
21(48)
25.9(28)
21.7 (20)
0.490
Prior MI % ()
18.1 (36)
19.6 (21)
16.3 (15)
0.544
CHF 2-3 NYHA % ()
69.0 (138)
59.3 (64)
80.4 (74)
0.001
Prior ischemic stroke % ()
25.5 (51)
19.4 (21)
32.6 (30)
0.033
Prior hemorrhagic stroke % ()
4 (8)
4.6 (5)
3.3 (3)
0.622
TIA % ()
6 (12)
6.5 (7)
5.4 (5)
0.756
Neurologic deficiency % ()
17.1 (34)
13.1 (14)
21.7 (20)
0.106
Major bleeding % ()
39.4 (78)
33.3 (36)
46.7 (42)
0.056
Carotid artery stenosis % ()
6 (12)
3.7 (4)
8.7 (8)
0.138
Hepatic dysfunction % ()
2.0 (4)
0.9 (1)
3.3 (3)
0.337
Interatrial shunting % ()
9.7 (19)
12.0 (13)
6.8 (6)
0.219
Alcohol abuse % ()
1.0 (2)
0.9 (1)
1.1 (1)
0.909
OAC % ()
0.198
Warfarin
62.6 (124)
66.7 (72)
57.8 (52)
NOAC
37.4 (74)
33.3 (36)
42.2 (38)
Labile INR % ()
67.7 (84)
65.3 (47)
71.1 (37)
0.490
CHA2DS2VASc score
4 (3-5)
3.5 (3-5)
4 (3-5)
0.193
HAS-BLED score
3 (3-3)
3 (2-3)
3 (3-3)
0.348
LA size (mm)
47 (42-52)
47 (42-51.5)
47 (41-52)
0.735
LVEF (%)
57 (51-61)
58 (52-60)
55 (50-63,5)
0.325
Values are presented as , % (), or median (interquartile range). AF, atrial fibrillation; AH, arterial hypertension; DM, diabetes mellitus; MI, myocardial infarction; CHF, congestive heart failure; TIA, transient ischemic attack; OAC, oral anticoagulant therapy; NOAC, non-Vitamin K antagonist oral anticoagulants; INR, international normalized ratio; LA, left atrium; LVEF, left ventricular ejection fraction.
